Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Writing Group for the Women's Health Initiative Investigators·2002·JAMA: The Journal of the American Medical Association

Cited by (1,144)

Items 701–800 of 1,144

  1. A review of the health care potential of bioactive compounds
    Lee Hooper, Aedín Cassidy · 2006 · Journal of the Science of Food and Agriculture
  2. The ongoing tyranny of statistical significance testing in biomedical research
    Andreas Stang, Charles Poole, Oliver Kuß · 2010 · European Journal of Epidemiology
  3. Stroke risk in women: the role of menopause and hormone therapy
    Lynda D. Lisabeth, Cheryl Bushnell · 2011 · The Lancet Neurology
  4. Sex Differences in Muscle Wasting
    Lindsey Jayne Anderson, Haiming M. Liu, José M. Garcia · 2017 · Advances in experimental medicine and biology
  5. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features
    John Paul Bilezikian, Maria Luisa Brandi, Mishaela Ruth Rubin, Shonni J. Silverberg · 2004 · Journal of Internal Medicine
  6. The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
    Menno Vergeer, Adriaan Georgius Holleboom, John J.P. Kastelein, Jan Albert Kuivenhoven · 2010 · Journal of Lipid Research
  7. Osteoporosis
    Julie T. Lin, Joseph M. Lane · 2004 · Clinical Orthopaedics and Related Research
  8. Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan
    Shalender Bhasin, Atam B. Singh, Ricky Phong Mac, Ballentine Carter, Martin I. Lee, Glenn R. Cunningham · 2003 · Journal of Andrology
  9. Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
    Sahni, Jasjeet Kaur, Doggui, Sihem, Ali, Javed, Baboota, Sanjula, Dao, Lé, Ramassamy, Charles · 2011 · Journal of Controlled Release
  10. The evolution of evidence hierarchies: what can Bradford Hill's ‘guidelines for causation’ contribute?
    Jeremy Howick, Paul Glasziou, Jeffrey K Aronson · 2009 · Journal of the Royal Society of Medicine
  11. Weight Gain, Body Mass Index, Hormone Replacement Therapy, and Postmenopausal Breast Cancer in a Large Prospective Study
    Heather Spencer Feigelson, Carolyn R. Jonas, Lauren R. Teras, Michael J. Thun, Eugenia E. Calle · 2004 · Cancer Epidemiology Biomarkers & Prevention
  12. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe
    Claudia Irene Stahlberg, Anette Tønnes Pedersen, Elsebeth Lynge, Zorana Jovanovic Andersen, Niels Keiding, Yrsa Andersen Hundrup, Erik B. Obel, Bent Ottesen · 2004 · International Journal of Cancer
  13. Epistemologic Inquiries in Evidence-Based Medicine
    Benjamin Djulbegović, Gordon Henry Guyatt, Richard Edmund Ashcroft · 2009 · Cancer Control
  14. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling
    Leiguo Ming, Keming Chen, Cory J. Xian · 2012 · Journal of Cellular Physiology
  15. Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity
    Gabriel M. Pagnotti, Maya Styner, Gunes Uzer, Vihitaben S. Patel, Laura E. Wright, Kirsten K. Ness, Theresa A. Guise, Janet E. Rubin, Clinton T. Rubin · 2019 · Nature Reviews Endocrinology
  16. Migraine and risk of stroke
    Lise Rystad Øie, Tobias Kurth, Sasha Gulati, David W. Dodick · 2020 · Journal of Neurology Neurosurgery & Psychiatry
  17. Osteoporosis: a review.
    Julie T. Lin, Joseph M. Lane · 2004 · PubMed
  18. Management of Glomerular Proteinuria: A Commentary
    Wilmer, William A., Rovin, Brad H., Hebert, Christopher J., Rao, Sunil V., Kumor, Karen, Hebert, Lee A. · 2003 · Journal of the American Society of Nephrology
  19. Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research
    Mary Beth Terry, Karin B. Michels, Julia Green Brody, Celia Byrne, Shiuan Chen, D. Joseph Jerry, Kristen M. C. Malecki, Mary Beth Martin, Rachel L. Miller, Susan L. Neuhausen et al. · 2019 · Breast Cancer Research
  20. Hormone therapy for postmenopausal women
    Pinkerton, JoAnn V. · 2020 · New England Journal of Medicine
  21. Assumptions of IV Methods for Observational Epidemiology.
    Didelez, Vanessa, Meng, Sha, Sheehan, Nuala A. · 2010 · Statistical Science
  22. Estrogen receptor-β mediates male-female differences in the development of pressure overload hypertrophy
    Maryanne Skavdahl, Charles Steenbergen, James A. Clark, Page Myers, Tracy K Demianenko, Lan Mao, Howard A. Rockman, Kenneth Steven Korach, Elizabeth Murphy · 2004 · American Journal of Physiology-Heart and Circulatory Physiology
  23. Setting a research agenda for medical overuse
    Daniel J. Morgan, Shannon Brownlee, Aaron L. Leppin, Nancy R. Kressin, Sanket Shishir Dhruva, Les Levin, Bruce E. Landon, Mark A. Zezza, Harald Schmidt, Vikas Saini et al. · 2015 · BMJ
  24. Gender as a Risk Factor for Advanced Neoplasia and Colorectal Cancer: A Systematic Review and Meta-analysis
    Stephen P. Nguyen, Stephen Bent, Yea‐Hung Chen, Jonathan P. Terdiman · 2009 · Clinical Gastroenterology and Hepatology
  25. The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
    Luiz Francisco Baccaro, Délio Marques Conde, Lúcia Costa‐Paiva, Aarão Mendes Pinto-Neto · 2015 · Clinical Interventions in Aging
  26. Aromatase expression and regulation in breast and endometrial cancer
    Hong Zhao, Ling Zhou, Anna Junjie Shangguan, Serdar Ekrem Bulun · 2016 · Journal of Molecular Endocrinology
  27. Steroid Hormones and Their Action in Women's Brains: The Importance of Hormonal Balance
    Juan Pablo Del Río, María I. Alliende, Natalia Molina, Felipe G. Serrano, Santiago Molina, Pilar Vigil P · 2018 · Frontiers in Public Health
  28. The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis
    Sangsang Li, Bingxin Guo, Huanan Chen, Zhan Shi, Yapeng Li, Qingfeng Tian, Songhe Shi · 2019 · Scientific Reports
  29. Hormone Replacement Therapy and the Cardiovascular System
    Pamela Ouyang, Erin D. Michos, Richard H. Karas · 2006 · Journal of the American College of Cardiology
  30. Management of Urinary Incontinence in Women
    Jayna Marie Holroyd-Leduc, Sharon Elizabeth Straus · 2004 · JAMA
  31. Estrogen-containing hormone therapy and Alzheimer’s disease risk: Understanding discrepant inferences from observational and experimental research
    Victor W. Henderson · 2005 · Neuroscience
  32. Sex steroid effects at target tissues: mechanisms of action
    Margaret E. Wierman · 2007 · AJP Advances in Physiology Education
  33. The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women After Prophylactic Salpingo-Oophorectomy
    Joanna B. Madalinska, Marc van Beurden, Eveline M. A. Bleiker, Heiddis Bjork Valdimarsdottir, Judith Hollenstein, Leon F.A.G. Massuger, Katja N. Gaarenstroom, Marian J.E. Mourits, René H.M. Verheijen, E.B.L. van Dorst et al. · 2006 · Journal of Clinical Oncology
  34. Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus
    J. David Curb, Ross L. Prentice, Paul F. Bray, Robert D. Langer, Linda Van Horn, Vanessa M. Barnabei, Michael J. Bloch, Michele G. Cyr, Margery L S Gass, Lisa A. Lepine et al. · 2006 · Archives of Internal Medicine
  35. Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient–Clinician Communications
    Sheryl A. Kingsberg, Jonathan Schaffir, Brooke M. Faught, JoAnn V. Pinkerton, Sharon J. Parish, Cheryl Bernadette Iglesia, Jennifer Gudeman, Julie S. Krop, James A. Simon · 2019 · Journal of Women s Health
  36. Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs
    Nicholas Cooney, Charles V. Pollack, Paul Butkerait · 2015 · Therapeutics and Clinical Risk Management
  37. The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer
    Carol J. Fabian · 2007 · International Journal of Clinical Practice
  38. The effect of conjugated equine oestrogen on diabetes incidence: the Women’s Health Initiative randomised trial
    Denise E. Bonds, Norman L. Lasser, Lihong Qi, Robert G. Brzyski, Bette Jane Caan, Gerardo M HEISS, Marian C. Limacher, JAMES H. LIU, Ellen D. Mason, Albert Oberman et al. · 2006 · Diabetologia
  39. The Risk of Hip Fractures in Older Individuals With Diabetes
    Lorraine Lucille Lipscombe, Sophie A. Jamal, Gillian L. Booth, GILLIAN A. HAWKER · 2007 · Diabetes Care
  40. Physiologic Aspects of Aging
    Rishi Sawhney, Mary Elizabeth Sehl, Arash Naeim · 2005 · The Cancer Journal
  41. Aromatase Cytochrome P450 and Extragonadal Estrogen Play a Role in Ischemic Neuroprotection
    Louise D. McCullough, Kathleen K. Blizzard, Evan R. Simpson, Orhan K. Öz, Patricia D. Hurn · 2003 · Journal of Neuroscience
  42. Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women
    Woraluk Somboonporn, Susan R. Davis · 2004 · Endocrine Reviews
  43. A simple and valid tool distinguished efficacy from effectiveness studies
    Gartlehner, Gerald, Hansen, Richard A., Nissman, Daniel, Lohr, Kathleen N., Carey, Timothy S. · 2006 · Journal of Clinical Epidemiology
  44. Hormone Therapy Prescribing Patterns in the United States
    Diana S.M. Buist, Katherine M. Newton, Diana L. Miglioretti, Kevin Beverly, Maureen T. Connelly, Susan Andrade, Cynthia L. Hartsfield, Feifei Wei, K. Arnold Chan, Larry G. Kessler · 2004 · Obstetrics and Gynecology
  45. Lipid metabolism in women
    Christine M. Williams · 2004 · Proceedings of The Nutrition Society
  46. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration
    Marcia L. Stefanick · 2005 · The American Journal of Medicine
  47. Progesterone Receptors Upregulate Wnt-1 To Induce Epidermal Growth Factor Receptor Transactivation and c-Src-Dependent Sustained Activation of Erk1/2 Mitogen-Activated Protein Kinase in Breast Cancer Cells
    Emily J. Faivre, Carol Ann Lange · 2006 · Molecular and Cellular Biology
  48. Effects of estrogen on the vascular system
    Tostes, R.C., Nigro, D., Fortes, Z.B., Carvalho, M.H.C. · 2003 · Brazilian Journal of Medical and Biological Research
  49. Cutting Edge: Cross-Regulation by TLR4 and T cell Ig Mucin-3 Determines Sex Differences in Inflammatory Heart Disease
    Frisancho-Kiss, Sylvia, Davis, Sarah E, Nyland, Jennifer F, Frisancho, J Augusto, Cihakova, Daniela, Barrett, Masheka A, Rose, Noel R, Fairweather, DeLisa · 2007 · The Journal of Immunology
  50. Signaling by estrogens
    Boris J. Cheskis, James Greger, Sunil Nagpal, Leonard P. Freedman · 2007 · Journal of Cellular Physiology
  51. The Relationship of Longitudinal Change in Reproductive Hormones and Vasomotor Symptoms during the Menopausal Transition
    John F. Randolph, MaryFran R Sowers, Irina Bondarenko, Ellen B. Gold, Gail A. Greendale, Joyce T. Bromberger, Sarah E. Brockwell, Karen A. Matthews · 2005 · The Journal of Clinical Endocrinology & Metabolism
  52. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women
    Francene M. Steinberg, Nicole L Guthrie, Amparo C. Villablanca, Kavita Kumar, Michael J. Murray · 2003 · American Journal of Clinical Nutrition
  53. The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties
    Lucas R. Chadwick, Guido F. Pauli, Norman R. Farnsworth · 2005 · Phytomedicine
  54. Pharmaceutical Prospects of Phytoestrogens
    Takeshi Usui · 2006 · Endocrine Journal
  55. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone
    Rowan T. Chlebowski, Thomas E. Rohan, JoAnn E. Manson, Aaron K. Aragaki, Andrew M. Kaunitz, Marcia L. Stefanick, Michael Steven Simon, Karen Johnson, Jean Wactawski‐Wende, Mary J. O’Sullivan et al. · 2015 · JAMA Oncology
  56. Risk of New Primary Nonbreast Cancers After Breast Cancer Treatment: A Dutch Population-Based Study
    Michael Schaapveld, Otto J. Visser, Marieke W.J. Louwman, Elisabeth G.E. de Vries, Pax H.B. Willemse, R. Otter, Winette T.A. van der Graaf, J.W.W. Coebergh, Flora E. van Leeuwen · 2008 · Journal of Clinical Oncology
  57. European cancer mortality predictions for the year 2018 with focus on colorectal cancer
    Matteo Malvezzi, Greta Carioli, Paola Bertuccio, Paolo Boffetta, Fabio Levi, Carlo La Vecchia, Eva Negri · 2018 · Annals of Oncology
  58. Preventing childhood obesity
    Thomas N. Robinson, John R. Sirard · 2005 · American Journal of Preventive Medicine
  59. Essential Epidemiology: An Introduction for Students and Health Professionals
    Penelope M. Webb, Chris Bain · 2012
  60. Epidemiology — identifying the causes and preventability of cancer?
    Graham A. Colditz, Thomas A. Sellers, Edward J. Trapido · 2005 · Nature reviews. Cancer
  61. Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women
    Kerrie L. Moreau · 2003 · Cardiovascular Research
  62. The Follicle-Deplete Mouse Ovary Produces Androgen1
    Loretta P. Mayer, Patrick J. Devine, Cheryl A. Dyer, Patricia B. Hoyer · 2004 · Biology of Reproduction
  63. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial
    Ayers, Beverley, Smith, Melanie, Hellier, Jennifer, Mann, Eleanor, Hunter, Myra S. · 2012 · Menopause
  64. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study
    Siân Sweetland, Valerie Beral, Angela Balkwill, Bette C Liu, Victoria S. Benson, Marianne Canonico, J Green, GILLIAN K. REEVES · 2012 · Journal of Thrombosis and Haemostasis
  65. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study
    Christel Renoux, Sophie Dell’Aniello, Samy Suissa · 2010 · Journal of Thrombosis and Haemostasis
  66. Antiresorptive therapies for osteoporosis: a clinical overview
    Jian Sheng Chen, Philip N. Sambrook · 2011 · Nature Reviews Endocrinology
  67. Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury
    Elizabeth B. Engler-Chiurazzi, Candice M. Brown, Jessica M. Povroznik, J.W. Simpkins · 2016 · Progress in Neurobiology
  68. Failure of Estrogen Plus Progestin Therapy for Prevention
    Suzanne W. Fletcher · 2002 · JAMA
  69. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure
    Langrish, Jeremy P., Mills, Nicholas L., Bath, Louise E., Warner, Pamela, Webb, David J., Kelnar, Christopher J., Critchley, Hilary O.D., Newby, David E., Wallace, W. Hamish B. · 2009 · Hypertension
  70. Estrogens and age-related memory decline in rodents: What have we learned and where do we go from here?
    Frick, Karyn M. · 2009 · Hormones and Behavior
  71. Role of estrogen in diastolic dysfunction
    Zhuo Zhao, Hao Wang, Jewell A. Jessup, Sarah Hoffmann Lindsey, Mark C. Chappell, Leanne Groban · 2014 · American Journal of Physiology-Heart and Circulatory Physiology
  72. Estrogen therapy and cognition: a review of the cholinergic hypothesis
    Gibbs, Robert B. · 2010 · Endocrine Reviews
  73. Bone Health and Osteoporosis
    Beatrice C. Lupsa, Karl Leonard Insogna · 2015 · Endocrinology and Metabolism Clinics of North America
  74. Incidence of breast cancer in a cohort of 5,135 transgender veterans
    George R. Brown, Kenneth T. Jones · 2014 · Breast Cancer Research and Treatment
  75. Osteoporosis – a current view of pharmacological prevention and treatment
    Julie C. Crockett, Das · 2013 · Drug Design Development and Therapy
  76. Association of Age at Menopause and Duration of Reproductive Period With Depression After Menopause
    Marios K. Georgakis, Thomas P. Thomopoulos, Andreas-Antonios Diamantaras, Eleni Ι. Kalogirou, Alkistis Skalkidou, Stella Styliani Daskalopoulou, Eleni Th. Petridou · 2016 · JAMA Psychiatry
  77. Estrogen Receptor-Mediated Rapid Signaling
    Katie Moriarty, K. H. Kim, Jeffrey R. Bender · 2006 · Endocrinology
  78. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies
    Tomas Riman, Staffan Nilsson, Ingemar R. Persson · 2004 · Acta Obstetricia Et Gynecologica Scandinavica
  79. Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study
    Rowan T. Chlebowski, JoAnn E. Manson, Garnet L. Anderson, Jane A. Cauley, Aaron K. Aragaki, Marcia L. Stefanick, Dorothy S. Lane, Karen Johnson, Jean Wactawski‐Wende, Chu Chen et al. · 2013 · JNCI Journal of the National Cancer Institute
  80. Health related quality of life after combined hormone replacement therapy: randomised controlled trial
    A J Welton, Madge R. Vickers, J. Kim, Deborah Ford, Beverley A. LAWTON, Alastair H Maclennan, Sarah K Meredith, Jeannett Martin, T W Meade, for the WISDOM team · 2008 · BMJ
  81. Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction
    Maria A. Cavasin, Steadman S. Sankey, Ai-Li Yu, Shreevidya Menon, Xiao-Ping Yang · 2003 · American Journal of Physiology-Heart and Circulatory Physiology
  82. Estrogen increases the number of spinophilin‐immunoreactive spines in the hippocampus of young and aged female rhesus monkeys
    J. Hao, W. Janssen, Yong Tang, Jeffrey A. Roberts, Heather M. McKay, B. Lasley, P. Allen, P. Greengard, P. Rapp, J. Kordower et al. · 2003 · The Journal of comparative neurology
  83. Bone-targeting macromolecular therapeutics
    D WANG, Scott C. Miller, Pavla Kopečková, Jindřich Kopeček · 2005 · Advanced Drug Delivery Reviews
  84. Soy foods, isoflavones, and the health of postmenopausal women
    Mark J. Messina · 2014 · American Journal of Clinical Nutrition
  85. Oestrogens and insulin secretion
    Ian F. Godsland · 2005 · Diabetologia
  86. Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial
    Rhonda R. Voskuhl, He-Jing Wang, T C Jackson Wu, Nancy L. Sicotte, Kunio Nakamura, Florian Kurth, Noriko Itoh, Jenny Bardens, Jacqueline T. Bernard, John R. Corboy et al. · 2015 · The Lancet Neurology
  87. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study
    Eila Suvanto‐Luukkonen, Riitta M. Koivunen, Helena Sundstr m, Risto Bloigu, Eija Karjalainen, Leena H iv -M llinen, Juha S. Tapanainen · 2005 · Menopause The Journal of The North American Menopause Society
  88. Clinical Applications of Vertebral Fracture Assessment by Dual-Energy X-Ray Absorptiometry
    Lewiecki, E. Michael, Laster, Andrew J. · 2006 · The Journal of Clinical Endocrinology & Metabolism
  89. Gender Differences in Cardiovascular Disease: Hormonal and Biochemical Influences
    Faustino Ramón Pérez-López, Luis Larrad-Mur, Amanda Nicole Kallen, Peter A. Chedraui, Hugh Stott Taylor · 2010 · Reproductive Sciences
  90. Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model
    Richard J. Santen, Norman F. Boyd, Rowan T. Chlebowski, Steven Ron Cummings, Jack M. Cuzick, Mitch Dowsett, Douglas F. Easton, John Forbes, Tim Key, Susan E. Hankinson et al. · 2007 · Endocrine Related Cancer
  91. A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working Group
    Jeff Jianfei Guo, Swapnil Pandey, John Doyle, Boyang Bian, Yvonne Lis, Dennis W. Raisch · 2010 · Value in Health
  92. Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein
    Levitan, Emily B., Cook, Nancy R., Stampfer, Meir J., Ridker, Paul M., Rexrode, Kathryn M., Buring, Julie E., Manson, JoAnn E., Liu, Simin · 2008 · Metabolism
  93. Short-term and long-term effects of osteoporosis therapies
    Ian R. Reid · 2015 · Nature Reviews Endocrinology
  94. Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women
    Shelley R. Salpeter, Ji Cheng, Lehana Thabane, Nicholas S. Buckley, E. E. Salpeter · 2009 · The American Journal of Medicine
  95. Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression
    Katherine M. Scarpin, J. Graham, P. Mote, C. Clarke · 2009 · Nuclear Receptor Signaling
  96. Estrogen: An Emerging Regulator of Insulin Action and Mitochondrial Function
    Anisha A. Gupte, Henry J. Pownall, Dale J. Hamilton · 2015 · Journal of Diabetes Research
  97. Clodronate Reduces the Incidence of Fractures in Community-Dwelling Elderly Women Unselected for Osteoporosis: Results of a Double-Blind, Placebo-Controlled Randomized Study
    Eugene Vincent McCloskey, Monique N.C. Beneton, Diane Charlesworth, Karthik Kayan, D. de Takats, Abhijit Dey, Jane Orgee, Robert U. Ashford, Martin David Forster, Jennifer Cliffe et al. · 2006 · Journal of Bone and Mineral Research
  98. Symptom Experience After Discontinuing Use of Estrogen Plus Progestin
    Judith K. Ockene · 2005 · JAMA
  99. Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina) (JCS 2013):– Digest Version –
    JCSJointWorkingGroup · 2014 · Circulation
  100. Population Distributions of C-reactive Protein in Apparently Healthy Men and Women in the United States: Implication for Clinical Interpretation
    Nader Rifai, Paul M. Ridker · 2003 · Clinical Chemistry